Plus   Neg

Alkermes Guides FY19 Revenues Higher Than Estimates - Quick Facts

Biopharmaceutical company Alkermes plc (ALKS) on Thursday initiated earnings and revenue for fiscal 2019. The company now projects earnings in a range of $0.87 to $1.06 per share and adjusted earnings in the range of $0.26 to $0.45 per share.

The company also said it now projects full-year 2018 revenues between $1.14 billion and $1.19 billion, up from its previous expectation range of $975 million to $1.025 billion, including expected Vivitrol net sales in a range of $330 million to $350 million, and Aristada net sales in a range of $210 million to $230 million.

The projected revenues are driven by expected about 24 percent growth of the company's proprietary products and an expected $150 million milestone payment from Biogen in the fourth quarter related to the potential FDA approval of diroximel fumarate.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $0.56 per share on revenues of $1.10 billion for the year. Analysts' estimates typically exclude special items.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Alibaba is upgrading its intellectual property system using blockchain technology, according to local news outlet Sohu. Alibaba Platform Management expects this to benefit mainly small and medium-sized enterprises, brands and entrepreneurs. The technology will be fully implemented in September, and thereafter, the company intends to expand it to the field of digital copyright protection. Electronics retailer Best Buy Co., Inc. (BBY) reported Thursday a 27 percent increase in profit for the first quarter from last year, which was impacted by restructuring charges, and higher revenues. Both adjusted earnings per share and revenues for the quarter topped analysts' estimates. The company also provides guidance for the second quarter and reiterated its outlook for the full-year 2020. While reporting financial results for the second quarter on Thursday, Hormel Foods Corp. (HRL) lowered its earnings and net sales guidance for the full-year 2019. For fiscal 2019, the company now projects earnings in a range of $1.71 to $1.85 per share, and net sales between $9.70 billion and $10.20...
Follow RTT